Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2 Meeting Abstract
| Authors: | Jhaveri, K.; O'Shaughnessy, J.; Fasching, P.; Cardoso, F.; Tolaney, S.; Hamilton, E.; Sharma, V. K.; Biswas, C.; Haftchenary, S.; Pathak, P.; Rugo, H. |
| Abstract Title: | Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2 |
| Meeting Title: | 13th European Breast Cancer Conference (EBCC-13) |
| Keywords: | treatment outcomes; antineoplastic agents, combined -- therapeutic use; breast neoplasms -- drug therapy; spain; letrozole -- therapeutic use; congresses and conferences -- spain |
| Journal Title: | European Journal of Cancer |
| Volume: | 175 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Nov 16-18 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-11-01 |
| Start Page: | S2 |
| End Page: | S3 |
| Language: | English |
| DOI: | 10.1016/s0959-8049(22)01353-3 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 3 Oral -- Source: Cinahl |
